Hill-Rom Holdings Upgraded to “Buy” by Goldman Sachs (HRC)
Hill-Rom Holdings (NYSE:HRC) was upgraded by Goldman Sachs from a “neutral” rating to a “buy” rating in a research note issued on Wednesday, TheFlyOnTheWall.com reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at Piper Jaffray raised their price target on shares of Hill-Rom Holdings from $40.00 to $43.00 in a research note on Wednesday. Separately, analysts at Morgan Stanley reiterated an “underweight” rating on shares of Hill-Rom Holdings in a research note on Friday, May 2nd. They now have a $36.00 price target on the stock. Finally, analysts at Northcoast Research downgraded shares of Hill-Rom Holdings from a “buy” rating to a “neutral” rating in a research note on Friday, April 11th. One analyst has rated the stock with a sell rating, six have given a hold rating and one has given a buy rating to the stock. The company presently has an average rating of “Hold” and an average price target of $41.97.
Shares of Hill-Rom Holdings (NYSE:HRC) traded up 0.95% during mid-day trading on Wednesday, hitting $40.59. The stock had a trading volume of 228,373 shares. Hill-Rom Holdings has a 1-year low of $32.85 and a 1-year high of $44.64. The stock has a 50-day moving average of $39. and a 200-day moving average of $38.92. The company has a market cap of $2.323 billion and a price-to-earnings ratio of 34.69.
Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings data on Friday, May 2nd. The company reported $0.57 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.51 by $0.06. The company had revenue of $415.00 million for the quarter, compared to the consensus estimate of $412.02 million. During the same quarter in the prior year, the company posted $0.49 earnings per share. The company’s quarterly revenue was down 2.4% on a year-over-year basis. Analysts expect that Hill-Rom Holdings will post $2.23 EPS for the current fiscal year.
Hill-Rom Holdings, Inc (NYSE:HRC) is a manufacturer and provider of medical technologies and related services for the health care industry, including patient care systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, surgical products and information technology solutions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.